Fundus cameras help in early detection and monitoring of chronic eye diseases such as Diabetic Retinopathy (DR), cataract, glaucoma, among others. These cameras are used to capture images of the fundus or the back of the eye. They are equipped with intricate microscopes enabling the photography of optic disc, retina, and macula.
Advanced Technology
The Hybrid Kowa VX-20 offers high quality, versatile, retinal imaging. The improved functionalities of this device include a-touch-of-a-button solution, which allows the operator to easily switch between non-mydriatic and mydriatic mode. Such devices are equipped with an easy-to-use wide color LCD touch screen that facilitates easy patient observation. Such devices enable simple singled-handed operation.
VX-20 has superior quality retinal imaging with several photography modes: Fundus Auto Fluorescence (FAF), Red-Free (RF), mydriatic color, non-mydriatic color, Fluorescein Angiography (FA), small pupil , and anterior. Stable chassis facilitate easier patient alignment and LED eye level mark makes eye testing in a darkroom convenient.
These devices enable saving of the captured images on a compact flash memory card and the images can be directly printed. They are also equipped with instant image filing software. The VX-20 offers mydriatic and FA modes with 50° and 30° views and non-mydriatic with 45° and 27°. Moreover, it has an FAF mode that further assists in the diagnostic investigation of retinal health and detection of Age-related Macular Degeneration (AMD).
The machine is linked to VK-2 software to provide outstanding fundus images. Photographic settings can be adjusted using simple operations, which makes these devices patient friendly. In the mydriatic color, FAF, RF, and FA modes, photography under monitor observation can reduce a patient’s photophobia. The capture mode enables users put in IDs and display the alignment of captured images.
Market Overview
According to a new report by Grand View Research Inc., the global fundus camera market is predicted at USD 625 million by 2024. Increasing prevalence of glaucoma, DR, and AMD is anticipated to drive the market.
Key Players
Some of the key players in the market are Topcon Medical Systems, Inc.; Canon, Inc.; NIDEK Co., Ltd.; and Optomed Oy Ltd. They adopt various strategies to sustain in the market: participate in launching of new products, expansion of global sales network, develop strategic partnerships, and invest in research & development.
No comments:
Post a Comment